A031501-PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION

January 05, 2020
https://clinicaltrials.gov/ct2/show/NCT03244384
Cancer - Bladder
Principal Investigator: Ding Wang, MD
Bladder cancer, urothelial carcinoma, advanced bladder cancer, muscle invasive bladder cancer
Accepting Participants
313-916-8862